These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8750184)

  • 41. Differential expression of CD44 splice variants in malignant and benign pleural effusions.
    Tojo N; Inase N; Ichioka M; Miyazato I; Nara N
    Tohoku J Exp Med; 1996 Aug; 179(4):273-9. PubMed ID: 8944429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis.
    Kasper M; Günthert U; Dall P; Kayser K; Schuh D; Haroske G; Müller M
    Am J Respir Cell Mol Biol; 1995 Dec; 13(6):648-56. PubMed ID: 7576702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined detection of CD44 isoforms by exon-specific RT-PCR and immunohistochemistry in primary human brain tumors and brain metastases.
    Frank S; Rihs HP; Stöcker W; Müller J; Dumont B; Baur X; Schackert HK; Schackert G
    Biochem Biophys Res Commun; 1996 May; 222(3):794-801. PubMed ID: 8651925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and cynomolgus monkeys.
    Heider KH; Mulder JW; Ostermann E; Susani S; Patzelt E; Pals ST; Adolf GR
    Eur J Cancer; 1995 Dec; 31A(13-14):2385-91. PubMed ID: 8652273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trans-acting factors regulate the expression of CD44 splice variants.
    Konig H; Moll J; Ponta H; Herrlich P
    EMBO J; 1996 Aug; 15(15):4030-9. PubMed ID: 8670907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of CD44v6 in adenocarcinoma of the pancreas: an immunohistochemical study.
    Castellà EM; Ariza A; Ojanguren I; Mate JL; Roca X; Fernández-Vasalo A; Navas-Palacios JJ
    Virchows Arch; 1996 Nov; 429(4-5):191-5. PubMed ID: 8972753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
    Sliutz G; Tempfer C; Winkler S; Kohlberger P; Reinthaller A; Kainz C
    Br J Cancer; 1995 Dec; 72(6):1494-7. PubMed ID: 8519665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD44 expression in metastatic and non-metastatic non-small cell lung cancers.
    Kargi HA; Kuyucuoğlu MF; Alakavuklar M; Akpinar O; Erk S
    Cancer Lett; 1997 Oct; 119(1):27-30. PubMed ID: 18372518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
    Ashida K; Terada T; Kitamura Y; Kaibara N
    Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
    Calikoglu E; Augsburger E; Chavaz P; Saurat JH; Kaya G
    J Cutan Pathol; 2003 Mar; 30(3):185-9. PubMed ID: 12641778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD44 variant exons in leukemia and lymphoma.
    Akisik E; Bavbek S; Dalay N
    Pathol Oncol Res; 2002; 8(1):36-40. PubMed ID: 11994761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of CD44 isoforms in human skin cancer.
    Simon JC; Heider KH; Dietrich A; Wuttig C; Schöpf E; Adolf GR; Ponta H; Herrlich P
    Eur J Cancer; 1996 Jul; 32A(8):1394-400. PubMed ID: 8869105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage are regulated at post-translational level in cells of melanocytic lineage.
    Gasbarri A; Del Prete F; Girnita L; Martegani MP; Natali PG; Bartolazzi A
    Melanoma Res; 2003 Aug; 13(4):325-37. PubMed ID: 12883358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
    Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD44 splice isoform switching determines breast cancer stem cell state.
    Zhang H; Brown RL; Wei Y; Zhao P; Liu S; Liu X; Deng Y; Hu X; Zhang J; Gao XD; Kang Y; Mercurio AM; Goel HL; Cheng C
    Genes Dev; 2019 Feb; 33(3-4):166-179. PubMed ID: 30692202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
    Sleeman J; Rudy W; Hofmann M; Moll J; Herrlich P; Ponta H
    J Cell Biol; 1996 Nov; 135(4):1139-50. PubMed ID: 8922392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of CD44(v5-10) splicing variants in primary ovarian cancer and lymph node metastases.
    Schröder W; Rudlowski C; Biesterfeld S; Knobloch C; Hauptmann S; Rath W
    Anticancer Res; 1999; 19(5B):3901-6. PubMed ID: 10628329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
    Afify A; Purnell P; Nguyen L
    Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.
    van Hal NL; van Dongen GA; Stigter-van Walsum M; Snow GB; Brakenhoff RH
    Int J Cancer; 1999 Sep; 82(6):837-45. PubMed ID: 10446451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.